Time to read: 1 minute read
Updated : Tue, January 16, 2018 @ 4:50 PM
Originally published : Tue, Jan 16, 2018 @ 10:35 AM
Updated : Tue, January 16, 2018 @ 4:50 PM
Originally published : Tue, Jan 16, 2018 @ 10:35 AM
Stellaris® RNA FISH (fluorescence in situ hybridization) is an RNA visualization method that allows simultaneous detection, localization, and quantification at the sub-cellular level in fixed samples using widefield or confocal fluorescence microscopy.
Recently, LGC's R&D Scientist Dr. Hans Johansson presented at the Helen Diller Cancer Institute at UCSF highlighting the basic chemistries and various downstream applications of Stellaris RNA FISH and how this technology can be used to support the oncology research being conducted at UCSF.
During the presentation Dr. Johansson also discusses:
specifics of designing Stellaris probe sets and how to validate for target specificity
compatibility with immunofluorescence (IF) and multiplexing multiple RNA targets
characterizing cell lines, disease phenotypes, allelic specific expression, transcription bursts, variant abundance, knock down, induced expression, nuclear RNAs and localization
If you weren't able to attend, or if you'd just like to catch it again, watch the presentation in its entirety below:
Interested in learning more about how RNA FISH is being used for cancer targets? Head on over to this page.
LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.
Leave a comment